NO20072806L - Aryloksy-substituerte benzimidazolderivater - Google Patents
Aryloksy-substituerte benzimidazolderivaterInfo
- Publication number
- NO20072806L NO20072806L NO20072806A NO20072806A NO20072806L NO 20072806 L NO20072806 L NO 20072806L NO 20072806 A NO20072806 A NO 20072806A NO 20072806 A NO20072806 A NO 20072806A NO 20072806 L NO20072806 L NO 20072806L
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen
- hydrogen
- integer
- carbon
- aryloxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Forbindelser med generell formel (I) eller farmasøytisk akseptable salter av disse, har glukokinaseaktiverende aktivitet og er anvendelige som terapeutiske midler for diabetes og fedme. I formel (I) er R1 og R2 hydrogen; R3 er hydrogen eller halogen; R4 er hydrogen eller lavere alkyl; Q er karbon, nitrogen eller svovel (forutsatt at svovelatomet kan være mono- eller disubstituert med okso); R5 og R6 er hydrogen eller lavere alkyl; X1, X2, X3 og X4 er uavhengig av hverandre karbon eller nitrogen; Z er oksygen, svovel eller nitrogen; Ar er aryl- eller heteroaryl; A er en 5- eller 6-leddet, nitrogenholdig, aromatisk, heterosyklisk gruppe; m er et helt tall fra 1 til 6; n er et helt tall fra 0 til 3; p er et helt tall fra 0 til 2 (forutsatt at minst to av X1-X4 er karbon); og q er 0 eller 1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004319339 | 2004-11-02 | ||
JP2005178628 | 2005-06-17 | ||
PCT/JP2005/020483 WO2006049304A1 (ja) | 2004-11-02 | 2005-11-01 | アリールオキシ置換ベンズイミダゾール誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072806L true NO20072806L (no) | 2007-07-27 |
Family
ID=36319300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072806A NO20072806L (no) | 2004-11-02 | 2007-06-01 | Aryloksy-substituerte benzimidazolderivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US7932394B2 (no) |
EP (1) | EP1810969B1 (no) |
JP (1) | JP5036316B2 (no) |
KR (1) | KR20070083939A (no) |
CN (1) | CN101094847B (no) |
AU (1) | AU2005301608B2 (no) |
BR (1) | BRPI0517232A (no) |
CA (1) | CA2586056C (no) |
CR (1) | CR9078A (no) |
EC (1) | ECSP077422A (no) |
IL (1) | IL182679A0 (no) |
MA (1) | MA29043B1 (no) |
MX (1) | MX2007005289A (no) |
NO (1) | NO20072806L (no) |
NZ (1) | NZ554440A (no) |
RU (1) | RU2398773C2 (no) |
WO (1) | WO2006049304A1 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0418212A (pt) * | 2003-12-29 | 2007-04-27 | Banyu Pharma Co Ltd | composto ou um sal deste farmaceuticamente aceitável, ativador da glicocinase, e, medicamentos para a terapia e/ou prevenção da diabete, e da obesidade |
US7994331B2 (en) * | 2005-07-13 | 2011-08-09 | Msd K.K. | Heterocycle-substituted benzimidazole derivative |
WO2007068894A2 (en) * | 2005-12-15 | 2007-06-21 | Astrazeneca Ab | Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
JP2010514828A (ja) | 2007-01-04 | 2010-05-06 | プロシディオン・リミテッド | ピペリジンgpcrアゴニスト |
CA2693997C (en) | 2007-08-03 | 2013-01-15 | Pierre L. Beaulieu | Viral polymerase inhibitors |
AU2008321959B2 (en) | 2007-11-12 | 2014-02-13 | Msd K.K. | Heteroaryloxy quinazoline derivative |
CN101903351B (zh) | 2007-12-19 | 2014-09-10 | 贝林格尔.英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
JP5364103B2 (ja) | 2007-12-20 | 2013-12-11 | エルジー・ライフ・サイエンシーズ・リミテッド | グルコキナーゼ活性化剤およびそれを活性成分として含有する医薬組成物 |
AU2009280579A1 (en) | 2008-08-15 | 2010-02-18 | Banyu Pharmaceutical Co.,Ltd. | Acetyl pyrrolidinyl indole derivative |
CA2734981A1 (en) * | 2008-08-29 | 2010-03-04 | Banyu Pharmaceutical Co., Ltd. | Oxotetrahydrofuran-2-yl-benzimidazole derivative |
CN101607923B (zh) * | 2009-07-21 | 2012-12-19 | 焦宁 | 芳基腈类化合物或其衍生物及其合成方法和应用 |
SG10201509157QA (en) * | 2010-11-09 | 2015-12-30 | Fujian Haixi Pharmaceuticals Inc | Compound for increasing kinase active and application thereof |
US20120258891A1 (en) | 2011-04-07 | 2012-10-11 | Nimblegen Systems Gmbh | Diarylsulfide backbone containing photolabile protecting groups |
WO2015161016A1 (en) * | 2014-04-17 | 2015-10-22 | Merck Sharp & Dohme Corp. | Bicyclic cgrp receptor antagonists |
TWI636049B (zh) * | 2015-11-17 | 2018-09-21 | 美商維愛美製藥公司 | 製備4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羥基-3-(1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈之方法 |
AR106729A1 (es) * | 2015-11-17 | 2018-02-14 | Viamet Pharmaceuticals Inc | 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-oxoetil)piridin-3-il)oxi)benzonitrilo y proceso para su preparación |
CA3005738C (en) * | 2015-11-17 | 2023-10-31 | Dow Agrosciences Llc | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation |
JP6928096B2 (ja) * | 2017-01-10 | 2021-09-01 | イーティーエイチ・チューリッヒ | 細胞保護化合物及びそれらの使用 |
IL309666A (en) | 2021-07-09 | 2024-02-01 | Plexium Inc | Aryl compounds and pharmaceutical preparations that modulate IKZF2 |
WO2024033677A1 (en) * | 2022-08-09 | 2024-02-15 | Faculdade De Farmácia Da Universidade De Lisboa | One-pot method for the synthesis of 3-acetamido-furfural from n-acetylglucosamine |
JP7356203B1 (ja) | 2023-08-03 | 2023-10-04 | Towa Corporation 株式会社 | WD and tetratricopeptide repeats 1遺伝子発現亢進用医薬組成物及び食品組成物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
DK337086A (da) * | 1985-08-12 | 1987-02-13 | Hoffmann La Roche | Benzimidazolderivater |
IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
US5349045A (en) | 1993-01-26 | 1994-09-20 | United States Surgical Corporation | Polymer derived from cyclic amide and medical devices manufactured therefrom |
PE92198A1 (es) | 1996-08-01 | 1999-01-09 | Banyu Pharma Co Ltd | Derivados de 1,4-piperidina disustituida que contienen fluor |
US20020032330A1 (en) * | 1996-12-24 | 2002-03-14 | Yutaka Nomura | Propionic acid derivatives |
JPH10306076A (ja) | 1997-03-06 | 1998-11-17 | Nippon Chemiphar Co Ltd | プロピオン酸誘導体 |
US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
DE60134679D1 (de) | 2000-10-20 | 2008-08-14 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische Heterozyklen |
US6433188B1 (en) * | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
AU2002221902B2 (en) | 2000-12-06 | 2006-11-23 | F. Hoffmann-La Roche Ag | Fused heteroaromatic glucokinase activators |
WO2003011836A1 (en) | 2001-08-01 | 2003-02-13 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
TW200408628A (en) | 2002-08-02 | 2004-06-01 | Sankyo Co | Resorcinol and its derivatives |
JP2004123711A (ja) | 2002-08-02 | 2004-04-22 | Sankyo Co Ltd | レゾルシノール誘導体 |
JP2004067629A (ja) | 2002-08-09 | 2004-03-04 | Yamanouchi Pharmaceut Co Ltd | ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体 |
NZ540791A (en) | 2003-02-13 | 2009-09-25 | Banyu Pharma Co Ltd | Novel 2-pyridinecarboxamide derivatives |
BRPI0418212A (pt) * | 2003-12-29 | 2007-04-27 | Banyu Pharma Co Ltd | composto ou um sal deste farmaceuticamente aceitável, ativador da glicocinase, e, medicamentos para a terapia e/ou prevenção da diabete, e da obesidade |
-
2005
- 2005-11-01 EP EP05803447.1A patent/EP1810969B1/en active Active
- 2005-11-01 BR BRPI0517232-2A patent/BRPI0517232A/pt not_active IP Right Cessation
- 2005-11-01 WO PCT/JP2005/020483 patent/WO2006049304A1/ja active Application Filing
- 2005-11-01 AU AU2005301608A patent/AU2005301608B2/en not_active Ceased
- 2005-11-01 CA CA2586056A patent/CA2586056C/en not_active Expired - Fee Related
- 2005-11-01 CN CN2005800456884A patent/CN101094847B/zh not_active Expired - Fee Related
- 2005-11-01 KR KR1020077010065A patent/KR20070083939A/ko not_active Application Discontinuation
- 2005-11-01 NZ NZ554440A patent/NZ554440A/en not_active IP Right Cessation
- 2005-11-01 US US11/666,555 patent/US7932394B2/en active Active
- 2005-11-01 JP JP2006542472A patent/JP5036316B2/ja not_active Expired - Fee Related
- 2005-11-01 RU RU2007120519/04A patent/RU2398773C2/ru not_active IP Right Cessation
- 2005-11-01 MX MX2007005289A patent/MX2007005289A/es active IP Right Grant
-
2007
- 2007-04-19 IL IL182679A patent/IL182679A0/en unknown
- 2007-04-20 CR CR9078A patent/CR9078A/es not_active Application Discontinuation
- 2007-04-27 EC EC2007007422A patent/ECSP077422A/es unknown
- 2007-05-28 MA MA29946A patent/MA29043B1/fr unknown
- 2007-06-01 NO NO20072806A patent/NO20072806L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006049304A1 (ja) | 2006-05-11 |
JP5036316B2 (ja) | 2012-09-26 |
AU2005301608A1 (en) | 2006-05-11 |
CN101094847B (zh) | 2011-06-15 |
EP1810969A4 (en) | 2011-05-25 |
CA2586056A1 (en) | 2006-05-11 |
CR9078A (es) | 2007-10-01 |
RU2398773C2 (ru) | 2010-09-10 |
JPWO2006049304A1 (ja) | 2008-05-29 |
EP1810969A1 (en) | 2007-07-25 |
RU2007120519A (ru) | 2008-12-10 |
NZ554440A (en) | 2010-01-29 |
BRPI0517232A (pt) | 2008-10-07 |
EP1810969B1 (en) | 2013-08-07 |
CN101094847A (zh) | 2007-12-26 |
MA29043B1 (fr) | 2007-11-01 |
AU2005301608B2 (en) | 2012-09-13 |
IL182679A0 (en) | 2007-09-20 |
CA2586056C (en) | 2012-03-13 |
KR20070083939A (ko) | 2007-08-24 |
ECSP077422A (es) | 2007-05-30 |
MX2007005289A (es) | 2007-07-19 |
US7932394B2 (en) | 2011-04-26 |
US20080125429A1 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072806L (no) | Aryloksy-substituerte benzimidazolderivater | |
NO20066015L (no) | Fuserte heterosykliske forbindelser | |
TW200736363A (en) | Material for organic electroluminescent device and organic electroluminescent device | |
MXPA05008619A (es) | Derivados novedosos de 2-piridincarboxamida. | |
NO20091793L (no) | 2-pyridinkarboksamidderivat med GK-aktiverende virkning | |
MXPA05009059A (es) | Derivados de heteroarilcarbamoilbenceno. | |
NO20075312L (no) | N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
ECSP066682A (es) | Derivado novedoso de bencimidazol 2-heteroaril-substituido | |
NO20083514L (no) | Heterobicykliske sulfonamidderivater for behandling av diabetes | |
NO20061076L (no) | (Tio)karbamoylsykloheksanderivater som D3/D2 -reseptorantagonister | |
NO20064089L (no) | Kondensert ring 4-oksopyrimidinderivat | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
NO20072632L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
MX2009010024A (es) | Nuevo compuesto de adenina. | |
WO2005097129A3 (en) | 6-azaindole compound | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
TN2010000091A1 (en) | Substituted pyrazole derivative | |
SG163617A1 (en) | Macrocyclic inhibitors of hepatitis c virus | |
NO20054852L (no) | GFAT inhibitorer | |
MX2009012885A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco | |
TW200745118A (en) | Macrocylic inhibitors of hepatitis C virus | |
NO20090952L (no) | N-(aminoheteroaryl) - lh - indol-2-karboksamidderivater og fremstilling og terapeutisk anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |